Senti Biosciences Holdings, Inc.
SNTI
$0.96
-$0.01-0.72%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -2,271.64% | 37.21% | -31.51% | -16.52% | 96.74% |
| Total Depreciation and Amortization | -4.70% | -4.44% | -5.87% | -5.89% | -36.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 150.53% | -90.58% | 251.94% | 205.61% | -403.46% |
| Change in Net Operating Assets | 121.92% | 73.79% | -128.08% | -453.50% | -116.94% |
| Cash from Operations | 49.09% | -20.09% | -56.66% | -20.27% | -91.90% |
| Capital Expenditure | 100.00% | -- | -- | -- | -175.00% |
| Sale of Property, Plant, and Equipment | -- | -100.00% | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | -100.00% | -- | -- | -110.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -78.57% | 1,260.00% | -- | -- | 8,371.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -76.35% | -100.49% | -- | -- | -- |
| Cash from Financing | -78.48% | -94.92% | -- | -- | 9,124.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -88.97% | -73.72% | -46.75% | -23.66% | 692.08% |